Michael W.Kobb (Mike)

Partner

New York + 1.212.326.3661

Connect:

Share

Mike Kobb's practice focuses on representing financial institutions, agents, borrowers, and sponsors in a variety of financing transactions with a focus on general corporate matters, finance, and capital markets. His experience includes acquisition financings, syndicated facilities, unsecured and secured lending transactions, senior and subordinated loans, and asset-backed loans, among other credit matters. Mike also has experience with high yield and investment-grade bond offerings, initial public and secondary equity offerings, and tender offers.

Prior to joining Jones Day, Mike was an associate in the New York office of an Am Law 100 law firm, where he was a member of that firm's corporate practice and worked on a wide range of financing and capital market transactions across a broad range of industries, including communications and media, health care, hospitality, data analytics, energy, scientific research, investment management, consumer packaging, and industrial manufacturing.

Before entering the legal profession, Mike worked for The Boeing Company where he participated in a fast-paced leadership rotation program in which he rotated through six finance and business-related positions over the course of two years. After the rotation program was completed, he joined the government contracts group within Boeing's Rotorcraft Division, where he was charged with, among other things, developing proposals and negotiating contracts with various U.S. military agencies.

Experience

  • Wabtec obtains $225 million term loan facilityJones Day represented Westinghouse Air Brake Technologies Corporation (“Wabtec”), a global provider of value-added, technology-based locomotives, equipment, systems and services for the freight rail and passenger transit industries, as well as the mining, marine, and industrial industries, in connection with its $225 million investment-grade term loan facility.
  • Webster Bank provides $95 million asset-based credit facility to leading cabinet manufacturerJones Day represented Webster Bank, N.A. as administrative agent, collateral agent, sole lead arranger, bookrunner, and a lender, in connection with a $95 million credit facility consisting of a $55 million revolving credit facility, a $25 million equipment credit facility, and a $15 million term loan facility, provided to one of the fastest growing cabinet manufacturers in the United States.
  • Webster Bank arranges $134 million secured credit facilityJones Day represented Webster Bank, N.A. in connection with a $134 million credit facility consisting of a $109 million term loan facility and a $25 million revolving credit facility provided to a leading U.S. manufacturer of private label take-and-bake pizzas and flatbreads.
  • Astellas acquires Iveric bioJones Day advised Astellas Pharma Inc. in the $5.9 billion cash acquisition of Iveric bio, Inc., a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet medical needs.
  • Webster Bank provides $25 million credit facility to research and archiving service provider in biopharmaceutical industryJones Day represented Webster Bank, N.A. as administrative agent, collateral agent, swingline lender, issuing bank, and as a lender, in connection with a $25 million credit facility to a certain group of borrowers and their subsidiaries which provide research and archiving services in the biopharmaceutical industry.
  • Large financial institution provides $150 million incremental revolving facility to mortgage lenderJones Day represented a large financial institution, as arranger, administrative agent, and lender, in connection with a $150 million incremental revolving facility provided to a mortgage lender, pursuant to an amendment and incremental joinder agreement to the credit agreement.
  • Webster Bank provides $33.25 million credit agreement to medical product manufacturerJones Day represented Webster Bank, N.A., as administrative agent, lender, and letter of credit issuer, in connection with a $33.25 million credit agreement, consisting of a $5 million revolving credit facility and a $28.25 million term loan facility, provided to an owner of a network of manufacturers of disposable medical and surgical products for ear, nose, and throat (ENT) and cosmetic/plastic surgery applications in the United States and United Kingdom.
  • Webster Bank provides $40 million financingJones Day represented Webster Bank, N.A. in connection with a $40 million financing, consisting of a senior secured revolving credit facility, senior secured term loan facility, and a senior secured delayed draw term loan facility.
  • Large financial institution provides $1 billion revolving credit facility to Bio-Techne CorporationJones Day represented a large financial institution, as administrative agent, in connection with a $1 billion revolving credit facility provided to Bio-Techne Corporation, a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostics.
  • Solmax acquires U.S. geosynthetics manufacturer PropexJones Day served as antitrust and financing counsel to Groupe Solmax Inc. (Solmax) in the acquisition by Solmax of Propex Operating Company, LLC, a leading geosynthetics manufacturer with a long track record in the construction, transportation, mining, and automotive industries.
  • Webster Bank provides $40 million credit agreement to Great Kitchens Food CompanyJones Day represented Webster Bank, N.A., as administrative agent, in connection with a $40 million credit agreement, consisting of a $10 million revolving credit facility and $30 million term loan facility, provided to Great Kitchens Food Company.
  • Skyworks Solutions acquires Infrastructure and Automotive business of Silicon Laboratories for $2.75 billionJones Day advised Skyworks Solutions, Inc., an innovator of high-performance analog semiconductors, in connection with its acquisition of the Infrastructure and Automotive business of Silicon Laboratories Inc. (NASDAQ: SLAB), a leading provider of silicon, software, and solutions, in an all-cash asset transaction valued at $2.75 billion.
  • Solmax acquires TenCate GeosyntheticsJones Day advised Groupe Solmax Inc. (Solmax), the global leader in the production of high-quality polyethylene geomembranes for industrial and environmental applications, and its shareholders (including institutional investors Caisse de dépot et placement du Québec and Fonds de Solidarité FTQ), in connection with Solmax’s acquisition of TenCate Geosynthetics Holding B.V., a global provider of geosynthetics and industrial fabrics, from Dutch conglomerate Koninklijke Ten Cate (Royal Ten Cate, the Netherlands), and advised on the related senior secured financing to support the acquisition.
  • Skyworks Solutions obtains $4.75 billion credit facilitiesJones Day represented Skyworks Solutions, Inc. in connection with its $4.75 billion credit facilities, consisting of a $1.5 billion term loan facility, a $750 million revolving credit facility, and a $2.5 billion 364-day bridge loan facility, with JP Morgan Chase Bank, N.A. and a syndicate of other lenders, for the acquisition of the Infrastructure and Automotive business of Silicon Laboratories Inc., a leading provider of silicon, software, and solutions.
  • Webster Bank provides revolving credit facility to Anasazi Medical Payment Solutions, Inc.Jones Day represented Webster Bank, N.A. as administrative agent, lender, and letter of credit issuer, in connection with its credit agreement with Anasazi Medical Payment Solutions, Inc. d/b/a Advanced Medical Pricing Solutions, an Arizona corporation and the owner of a network of providers of healthcare cost management services in the United States.
  • Verint Systems completes $315 million Convertible Notes offeringJones Day represented Verint Systems Inc., a provider of Actionable Intelligence® solutions and value-added services, in connection with an offering of $315 million aggregate principal amount of 0.25% Convertible Senior Notes due 2026.
  • Webster Bank provides $17 million credit agreement to U.S. Urology Partners, LLCJones Day represented Webster Bank, N.A., as agent for all lenders, collateral agent, lender, and letter of credit issuer, in connection with a new $17 million credit agreement with U.S. Urology Partners, LLC, the owner of a network of urology practices in the United States, which was used to fund a portion of the borrower's acquisition of a new urology practice and the assets of a urology practice.
  • Webster Bank provides $28 million credit agreement to MyOrthos Holdings, LLCJones Day represented Webster Bank, N.A., as administrative agent, collateral agent, lender, and letter of credit issuer, in connection with a new $28 million credit agreement with MyOrthos Holdings, LLC, owner of a network of orthodontic practices in the United States, which was used to fund a portion of the borrower's acquisition of a new orthodontic practice.
  • Merchant banking firm provides $122.5 million acquisition financing to provider of construction accounting software and payroll servicesJones Day advised a merchant banking firm in connection with a $122.5 million senior secured credit facility, comprised of a $110 million term loan and a $12.5 million revolving credit facility, supporting the acquisition of a leading provider of construction accounting software and payroll services for small- to mid-sized specialty contractors in Ohio.
  • Wells Fargo amends and restates loan and security agreement for distributor of PET resinsJones Day represented Wells Fargo Bank, National Association, as administrative agent and collateral agent, and Wells Fargo Bank, National Association, London Branch, as foreign collateral agent, in connection with the third amended and restated loan and security agreement provided to a distributor of virgin and recycled polyethylene terephthalate resins.
    • View All

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.